Palo Alto Investors’s AVEO Pharmaceuticals, Inc. AVEO Stock Holding History

Palo Alto Investors’s Portfolio AVEO Stock Details AVEO Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2015 Q1	–	Sell	-66,945	Closed	-$562K	–	47
2014 Q4	$562K	Sell	66,945 -28,858	-30%	-$264K	0.03%	43
2014 Q3	$1.06M	Sell	95,803 -24,277	-20%	-$309K	0.08%	40
2014 Q2	$2.2M	Sell	120,080 -22,837	-16%	-$297K	0.16%	38
2014 Q1	$2.14M	Hold	142,917	–	–	0.18%	31
2013 Q4	$2.62M	Sell	142,917 -208,004	-59%	-$4.17M	0.24%	28
2013 Q3	$7.23M	Hold	350,921	–	–	0.76%	23
2013 Q2	$8.77M	Buy	+350,921	New	+$15M	1.04%	20

Other funds holding AVEO

SCM

Sarissa Capital Management Greenwich, Connecticut $158M AUM 103.7% 1-Year Est. Return

BIT

BlackRock Institutional Trust San Francisco, California $675B AUM 16.26% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

GCM

Gruss Capital Management New York $715M AUM 9.91% 1-Year Est. Return

Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return

GIM

Granahan Investment Management Waltham, Massachusetts $2.07B AUM 56.45% 1-Year Est. Return

DVC

Deer VI & Co Larchmont, New York $2.23M AUM 9.32% 1-Year Est. Return

ACP

Acuta Capital Partners Redwood City, California $142M AUM 783.79% 1-Year Est. Return

Greylock XI Cambridge, Massachusetts $7.71M AUM 28.23% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Palo Alto Investors's AVEO Position: Q1 2015 in Review

Palo Alto Investors sold out of AVEO Pharmaceuticals, Inc. (AVEO) in Q1 2015, closing a stake of 66,945 shares — an estimated $562K sold.

Palo Alto Investors first reported a position in AVEO in Q2 2013 and held it in 7 quarters. The position peaked at $8.77M in Q2 2013. 49 funds tracked by Wall St. Rank hold AVEO as of Q1 2015.

Palo Alto Investors reported no remaining AVEO Pharmaceuticals, Inc. position as of Q1 2015 after selling out during the quarter.
Palo Alto Investors sold 66,945 AVEO Pharmaceuticals, Inc. shares in Q1 2015, an estimated $562K.
Palo Alto Investors first reported a position in AVEO Pharmaceuticals, Inc. in Q2 2013 and held it in 7 quarters.
Palo Alto Investors's AVEO Pharmaceuticals, Inc. position peaked at $8.77M in Q2 2013.
49 funds tracked by Wall St. Rank held AVEO Pharmaceuticals, Inc. as of Q1 2015.

Based on Palo Alto Investors's 13F filing for Q1 2015, filed 15 May 2015.